Antigen-specific cytotoxic CD8+ T-lymphocytes (CTLs) are potent effectors able to specifically recognize and lyse infected or malignant cells; however, their development through efficient vaccines for the treatment of infectious diseases or cancers remains a challenge. The gene discussed is CD8A; the disease is cancer.